Improvements in Treatment Access are Helping Indigenous Chronic Kidney Disease Patients, but More Changes are Needed
1662222 / Pixabay

Improvements in Treatment Access are Helping Indigenous Chronic Kidney Disease Patients, but More Changes are Needed

According to a story from abc.net.au, the local health services from northwest Queensland, Australia have recently been tasked with managing dialysis treatment centers in the region. This has improved access…

Continue Reading Improvements in Treatment Access are Helping Indigenous Chronic Kidney Disease Patients, but More Changes are Needed

Chiari Malformation Patient Hasn’t Let 6 Brain Surgeries or a Stroke Stop Her from Continuing Medical School

The Beginning of the Journey Claudia Martinez is a medical student at UTHealth McGovern Medical School. Her dream is, and always has been, to be a doctor. But an unexpected…

Continue Reading Chiari Malformation Patient Hasn’t Let 6 Brain Surgeries or a Stroke Stop Her from Continuing Medical School
After Diagnosis, This Man Traced the Origins of His Family’s hATTR Amyloidosis
Free-Photos / Pixabay

After Diagnosis, This Man Traced the Origins of His Family’s hATTR Amyloidosis

According to a story from Wapakoneta Daily News, Greg was devastated when he learned that his brother was diagnosed with hereditary transthyretin mediated (hATTR) amyloidosis. Ultimately, the disease would take…

Continue Reading After Diagnosis, This Man Traced the Origins of His Family’s hATTR Amyloidosis
First Treatment in China for Morquio A Syndrome Earns Approval
Free-Photos / Pixabay

First Treatment in China for Morquio A Syndrome Earns Approval

According to a story from Market Screener, the biotechnology company BioMarin Pharmaceutical Inc. recently announced that the Chinese government has approved the company's drug elosulfase alfa (marketed at Vimizim) as…

Continue Reading First Treatment in China for Morquio A Syndrome Earns Approval
Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
mohamed_hassan / Pixabay

Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

According to a story from BioPortfolio, AstraZeneca and Merck have recently announced the results from a phase 3 clinical trial testing olaparib (marketed as LYNPARZA®) as a treatment for BRCA…

Continue Reading Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

Study Links IL-1 Cytokines to Increased Scarring in Systemic Scleroderma Patients

According to a publication from Scleroderma News, a study recently published in Clinical & Transitional Immunology suggests that certain cytokines (small proteins that play an important role in communication between…

Continue Reading Study Links IL-1 Cytokines to Increased Scarring in Systemic Scleroderma Patients
Close Menu